The Pancreas Center offers multiple and innovative surgical options for resection of pancreatic neoplasms. Our procedural experience leads to high success rates for our patients.
The specialists at The Pancreas Center are constantly innovating and improving surgical procedures for pancreatic cancer. They are able to customize pancreas surgery and preserve more healthy tissue, while still safely removing tumors.
The Pancreas Center team is also focused on identifying and treating precancerous lesions like IPMN. Due to the increasing number of patients seen each year, the team is adept at recognizing these precancerous conditions and delivering the most appropriate treatment for each individual patient.
Pancreas Center Surgery Team
John Chabot, MD
Beth Schrope, MD, PhD
Surgical Innovations and Advances
Surgery is the standard treatment for pancreatic cancer. Unfortunately 1/3 of patients are inoperable due to vascular invasion. Here at The Pancreas Center, neoadjuvant chemotherapy has become a valued tool in treating inoperable patients, thereby increasing the surgical option for the 35% of patients with locally inoperable disease.
Patients with advanced pancreatic cancer deemed to be surgically unresectable are often able to undergo a regimen of neoadjuvant chemotherapy and radiation therapy that reduces their disease to operable levels.
Patients with tumors encroaching on and encasing vessels are operated on at our institution with a high success rate. Often this is combined with neoadjuvant therapy.
Laparoscopic Distal Pancreatectomy
Patients can safely undergo distal pancreatectomies laparoscopically. At our institution, the majority of these laparoscopic pancreatectomies are for neuroendocrine tumors and cysts. Our laparoscopic distal pancreas patients tend to experience shorter hospital stays, less blood loss, and lower leak and complication rates.
Central pancreatectomies are performed at The Pancreas Center. These operations can eradicate a neoplasm in the body or neck of the pancreas without removing the healthy pancreatic tail; enabling the patient to have a highly functioning pancreatic head and tail with exocrine and endocrine functions intact.
Recent Surgery Publications and Presentations
- Allendorf JD, Lauerman M, Bill A, Digiorgi M, Goetz N, Vakiani E, Remotti H, Schrope B, Sherman W, Hall M, Fine RL, Chabot JA. Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Feasibility, Efficacy, and Survival. J Gastrointest Surg. 2008 Jan;12(1):91-100 Epub 2007 Sep 5
- Fisher JC, Kuenzler K A, Bodenstein L, Chabot J A. Central Pancreatectomy with Pancreaticogastrostomy in Children. J Pediatric Surg. 2007 Apr; 42 (4), 740-6.
- Allendorf JD, Schrope BA, Lauerman MH, Inabnet WB, Chabot JA. Postoperative glycemic control after central pancreatectomy for mid-gland lesions. World J Surg. 2007 Jan;31(1):164-8; discussion 169-70.
- Pancreatectomy with vascular resection and reconstruction: A single institution 12 year experience. Presented by John Allendorf, MD, April 18, 2007. Presented to the New York Surgical Society at the New York Academy of Medicine, New York, NY.
- Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Safety, Feasibility, and Survival. Presented by John Allendorf, MD, at SAGES/AHPBA Conference, April 18-22, 2007, Las Vegas, NV.
- A Single-Institution Review of Laparoscopic and Open Distal Pancreatectomies. Presented by Beth Schrope, MD, PhD, at SAGES/AHPBA Conference, April 18-22, 2007.